Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 156 of 165 entries
Sorted by: Best Match Show Resources per page
Filters applied: Corrected and Republished Article
More on the history of pediatrics.

Pediatric annals

Reich JD.
PMID: 9575068
Pediatr Ann. 1997 Dec;26(12):712. doi: 10.3928/0090-4481-19971201-05.

No abstract available.

Cite
Reich JD. More on the history of pediatrics. Pediatr Ann. 1997;26(12):712doi: 10.3928/0090-4481-19971201-05.
Reich, J. D. (1997). More on the history of pediatrics. Pediatric annals, 26(12), 712. https://doi.org/10.3928/0090-4481-19971201-05
Reich, J D. "More on the history of pediatrics." Pediatric annals vol. 26,12 (1997): 712. doi: https://doi.org/10.3928/0090-4481-19971201-05
Reich JD. More on the history of pediatrics. Pediatr Ann. 1997 Dec;26(12):712. doi: 10.3928/0090-4481-19971201-05. PMID: 9575068.
Copy Download .nbib Format: NLM
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.

The New England journal of medicine

Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA.
PMID: 29897866
N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13.

BACKGROUND: Observational cohort studies and a secondary prevention trial have shown inverse associations between adherence to the Mediterranean diet and cardiovascular risk.METHODS: In a multicenter trial in Spain, we assigned 7447 participants (55 to 80 years of age, 57%...

Cite
Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34doi: 10.1056/NEJMoa1800389.
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., Lamuela-Raventos, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A., Sorlí, J. V., Martínez, J. A., Fitó, M., Gea, A., Hernán, M. A., Martínez-González, M. A. (2018). Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. The New England journal of medicine, 378(25), e34. https://doi.org/10.1056/NEJMoa1800389
Estruch, Ramón, et al. "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts." The New England journal of medicine vol. 378,25 (2018): e34. doi: https://doi.org/10.1056/NEJMoa1800389
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13. PMID: 29897866.
Copy Download .nbib Format: NLM
Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

Drug and therapeutics bulletin

DiMaria C, Hanna W, Murone J, Reichart J.
PMID: 31624064
Drug Ther Bull. 2019 Nov;57(11):173-175. doi: 10.1136/dtb.2019.230371rep. Epub 2019 Oct 17.

No abstract available.

Cite
DiMaria C, Hanna W, Murone J, et al. Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis. Drug Ther Bull. 2019;57(11):173-175doi: 10.1136/dtb.2019.230371rep.
DiMaria, C., Hanna, W., Murone, J., & Reichart, J. (2019). Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis. Drug and therapeutics bulletin, 57(11), 173-175. https://doi.org/10.1136/dtb.2019.230371rep
DiMaria, Christina, et al. "Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis." Drug and therapeutics bulletin vol. 57,11 (2019): 173-175. doi: https://doi.org/10.1136/dtb.2019.230371rep
DiMaria C, Hanna W, Murone J, Reichart J. Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis. Drug Ther Bull. 2019 Nov;57(11):173-175. doi: 10.1136/dtb.2019.230371rep. Epub 2019 Oct 17. PMID: 31624064.
Copy Download .nbib Format: NLM
Andexxa-An Antidote for Apixaban and Rivaroxaban.

JAMA

[No authors listed]
PMID: 30043058
JAMA. 2018 Jul 24;320(4):399-400. doi: 10.1001/jama.2018.9257.

No abstract available.

Cite
Andexxa-An Antidote for Apixaban and Rivaroxaban. JAMA. 2018;320(4):399-400doi: 10.1001/jama.2018.9257.
(2018). Andexxa-An Antidote for Apixaban and Rivaroxaban. JAMA, 320(4), 399-400. https://doi.org/10.1001/jama.2018.9257
"Andexxa-An Antidote for Apixaban and Rivaroxaban." JAMA vol. 320,4 (2018): 399-400. doi: https://doi.org/10.1001/jama.2018.9257
Andexxa-An Antidote for Apixaban and Rivaroxaban. JAMA. 2018 Jul 24;320(4):399-400. doi: 10.1001/jama.2018.9257. PMID: 30043058.
Copy Download .nbib Format: NLM
Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis.

Drug and therapeutics bulletin

Beverstock A, Kelly A.
PMID: 31444222
Drug Ther Bull. 2019 Oct;57(10):158-159. doi: 10.1136/dtb.2019.229803rep. Epub 2019 Aug 23.

No abstract available.

Cite
Beverstock A, Kelly A. Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis. Drug Ther Bull. 2019;57(10):158-159doi: 10.1136/dtb.2019.229803rep.
Beverstock, A., & Kelly, A. (2019). Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis. Drug and therapeutics bulletin, 57(10), 158-159. https://doi.org/10.1136/dtb.2019.229803rep
Beverstock, Andrew, and Kelly, Alison. "Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis." Drug and therapeutics bulletin vol. 57,10 (2019): 158-159. doi: https://doi.org/10.1136/dtb.2019.229803rep
Beverstock A, Kelly A. Republished: Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis. Drug Ther Bull. 2019 Oct;57(10):158-159. doi: 10.1136/dtb.2019.229803rep. Epub 2019 Aug 23. PMID: 31444222; PMCID: PMC6837250.
Copy Download .nbib Format: NLM
Drugs for Postmenopausal Osteoporosis.

JAMA

[No authors listed]
PMID: 31184738
JAMA. 2019 Jun 11;321(22):2233-2234. doi: 10.1001/jama.2019.6077.

No abstract available.

Cite
Drugs for Postmenopausal Osteoporosis. JAMA. 2019;321(22):2233-2234doi: 10.1001/jama.2019.6077.
(2019). Drugs for Postmenopausal Osteoporosis. JAMA, 321(22), 2233-2234. https://doi.org/10.1001/jama.2019.6077
"Drugs for Postmenopausal Osteoporosis." JAMA vol. 321,22 (2019): 2233-2234. doi: https://doi.org/10.1001/jama.2019.6077
Drugs for Postmenopausal Osteoporosis. JAMA. 2019 Jun 11;321(22):2233-2234. doi: 10.1001/jama.2019.6077. PMID: 31184738.
Copy Download .nbib Format: NLM
Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis.

Drug and therapeutics bulletin

Leader R, Cowen J, Rajeev SP.
PMID: 31784467
Drug Ther Bull. 2020 Apr;58(4):60-63. doi: 10.1136/dtb.2019.231104rep. Epub 2019 Nov 29.

No abstract available.

Cite
Leader R, Cowen J, Rajeev SP. Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis. Drug Ther Bull. 2019;58(4):60-63doi: 10.1136/dtb.2019.231104rep.
Leader, R., Cowen, J., & Rajeev, S. P. (2020). Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis. Drug and therapeutics bulletin, 58(4), 60-63. https://doi.org/10.1136/dtb.2019.231104rep
Leader, Ross, et al. "Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis." Drug and therapeutics bulletin vol. 58,4 (2020): 60-63. doi: https://doi.org/10.1136/dtb.2019.231104rep
Leader R, Cowen J, Rajeev SP. Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis. Drug Ther Bull. 2020 Apr;58(4):60-63. doi: 10.1136/dtb.2019.231104rep. Epub 2019 Nov 29. PMID: 31784467.
Copy Download .nbib Format: NLM
Republished: Sertraline-induced hypersensitivity pneumonitis.

Drug and therapeutics bulletin

Virdee G, Bleasdale J, Ikramullah M, Graham-Clarke E.
PMID: 32188684
Drug Ther Bull. 2020 May;58(5):75-79. doi: 10.1136/dtb.2019.230724rep. Epub 2020 Mar 18.

No abstract available.

Cite
Virdee G, Bleasdale J, Ikramullah M, et al. Republished: Sertraline-induced hypersensitivity pneumonitis. Drug Ther Bull. 2020;58(5):75-79doi: 10.1136/dtb.2019.230724rep.
Virdee, G., Bleasdale, J., Ikramullah, M., & Graham-Clarke, E. (2020). Republished: Sertraline-induced hypersensitivity pneumonitis. Drug and therapeutics bulletin, 58(5), 75-79. https://doi.org/10.1136/dtb.2019.230724rep
Virdee, Gursharan, et al. "Republished: Sertraline-induced hypersensitivity pneumonitis." Drug and therapeutics bulletin vol. 58,5 (2020): 75-79. doi: https://doi.org/10.1136/dtb.2019.230724rep
Virdee G, Bleasdale J, Ikramullah M, Graham-Clarke E. Republished: Sertraline-induced hypersensitivity pneumonitis. Drug Ther Bull. 2020 May;58(5):75-79. doi: 10.1136/dtb.2019.230724rep. Epub 2020 Mar 18. PMID: 32188684.
Copy Download .nbib Format: NLM
Peanut Allergen Powder (Palforzia).

JAMA

[No authors listed]
PMID: 32662860
JAMA. 2020 Jul 14;324(2):192-193. doi: 10.1001/jama.2020.3599.

No abstract available.

Cite
Peanut Allergen Powder (Palforzia). JAMA. 2020;324(2):192-193doi: 10.1001/jama.2020.3599.
(2020). Peanut Allergen Powder (Palforzia). JAMA, 324(2), 192-193. https://doi.org/10.1001/jama.2020.3599
"Peanut Allergen Powder (Palforzia)." JAMA vol. 324,2 (2020): 192-193. doi: https://doi.org/10.1001/jama.2020.3599
Peanut Allergen Powder (Palforzia). JAMA. 2020 Jul 14;324(2):192-193. doi: 10.1001/jama.2020.3599. PMID: 32662860.
Copy Download .nbib Format: NLM
Republished: Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application.

Drug and therapeutics bulletin

Walters E, Wurster Ovalle V, Yin S, Dribin T.
PMID: 32527849
Drug Ther Bull. 2020 Sep;58(9):141-143. doi: 10.1136/dtb.2020.233119rep. Epub 2020 Jun 11.

No abstract available.

Cite
Walters E, Wurster Ovalle V, Yin S, et al. Republished: Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application. Drug Ther Bull. 2020;58(9):141-143doi: 10.1136/dtb.2020.233119rep.
Walters, E., Wurster Ovalle, V., Yin, S., & Dribin, T. (2020). Republished: Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application. Drug and therapeutics bulletin, 58(9), 141-143. https://doi.org/10.1136/dtb.2020.233119rep
Walters, Erica, et al. "Republished: Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application." Drug and therapeutics bulletin vol. 58,9 (2020): 141-143. doi: https://doi.org/10.1136/dtb.2020.233119rep
Walters E, Wurster Ovalle V, Yin S, Dribin T. Republished: Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application. Drug Ther Bull. 2020 Sep;58(9):141-143. doi: 10.1136/dtb.2020.233119rep. Epub 2020 Jun 11. PMID: 32527849.
Copy Download .nbib Format: NLM
Confronting Racism in Chemistry Journals.

Molecular pharmaceutics

Burrows CJ, Huang J, Wang S, Kim HJ, Meyer GJ, Schanze K, Lee TR, Lutkenhaus JL, Kaplan D, Jones C, Bertozzi C, Kiessling L, Mulcahy MB, Lindsley CW, Finn MG, Blum JD, Kamat P, Choi W, Snyder S, Aldrich CC, Rowan S, Liu B, Liotta D, Weiss PS, Zhang D, Ganesh KN, Atwater HA, Gooding JJ, Allen DT, Voigt CA, Sweedler J, Schepartz A, Rotello V, Lecommandoux S, Sturla SJ, Hammes-Schiffer S, Buriak J, Steed JW, Wu H, Zimmerman J, Brooks B, Savage P, Tolman W, Hofmann TF, Brennecke JF, Holme TA, Merz KM, Scuseria G, Jorgensen W, Georg GI, Wang S, Proteau P, Yates JR, Stang P, Walker GC, Hillmyer M, Taylor LS, Odom TW, Carreira E, Rossen K, Chirik P, Miller SJ, Shea JE, McCoy A, Zanni M, Hartland G, Scholes G, Loo JA, Milne J, Tegen SB, Kulp DT, Laskin J.
PMID: 32559104
Mol Pharm. 2020 Jul 06;17(7):2229-2231. doi: 10.1021/acs.molpharmaceut.0c00638. Epub 2020 Jun 19.

No abstract available.

Cite
Burrows CJ, Huang J, Wang S, et al. Confronting Racism in Chemistry Journals. Mol Pharm. 2020;17(7):2229-2231doi: 10.1021/acs.molpharmaceut.0c00638.
Burrows, C. J., Huang, J., Wang, S., Kim, H. J., Meyer, G. J., Schanze, K., Lee, T. R., Lutkenhaus, J. L., Kaplan, D., Jones, C., Bertozzi, C., Kiessling, L., Mulcahy, M. B., Lindsley, C. W., Finn, M. G., Blum, J. D., Kamat, P., Choi, W., Snyder, S., Aldrich, C. C., Rowan, S., Liu, B., Liotta, D., Weiss, P. S., Zhang, D., Ganesh, K. N., Atwater, H. A., Gooding, J. J., Allen, D. T., Voigt, C. A., Sweedler, J., Schepartz, A., Rotello, V., Lecommandoux, S., Sturla, S. J., Hammes-Schiffer, S., Buriak, J., Steed, J. W., Wu, H., Zimmerman, J., Brooks, B., Savage, P., Tolman, W., Hofmann, T. F., Brennecke, J. F., Holme, T. A., Merz, K. M., Scuseria, G., Jorgensen, W., Georg, G. I., Wang, S., Proteau, P., Yates, J. R., Stang, P., Walker, G. C., Hillmyer, M., Taylor, L. S., Odom, T. W., Carreira, E., Rossen, K., Chirik, P., Miller, S. J., Shea, J. E., McCoy, A., Zanni, M., Hartland, G., Scholes, G., Loo, J. A., Milne, J., Tegen, S. B., Kulp, D. T., & Laskin, J. (2020). Confronting Racism in Chemistry Journals. Molecular pharmaceutics, 17(7), 2229-2231. https://doi.org/10.1021/acs.molpharmaceut.0c00638
Burrows, Cynthia J, et al. "Confronting Racism in Chemistry Journals." Molecular pharmaceutics vol. 17,7 (2020): 2229-2231. doi: https://doi.org/10.1021/acs.molpharmaceut.0c00638
Burrows CJ, Huang J, Wang S, Kim HJ, Meyer GJ, Schanze K, Lee TR, Lutkenhaus JL, Kaplan D, Jones C, Bertozzi C, Kiessling L, Mulcahy MB, Lindsley CW, Finn MG, Blum JD, Kamat P, Choi W, Snyder S, Aldrich CC, Rowan S, Liu B, Liotta D, Weiss PS, Zhang D, Ganesh KN, Atwater HA, Gooding JJ, Allen DT, Voigt CA, Sweedler J, Schepartz A, Rotello V, Lecommandoux S, Sturla SJ, Hammes-Schiffer S, Buriak J, Steed JW, Wu H, Zimmerman J, Brooks B, Savage P, Tolman W, Hofmann TF, Brennecke JF, Holme TA, Merz KM, Scuseria G, Jorgensen W, Georg GI, Wang S, Proteau P, Yates JR, Stang P, Walker GC, Hillmyer M, Taylor LS, Odom TW, Carreira E, Rossen K, Chirik P, Miller SJ, Shea JE, McCoy A, Zanni M, Hartland G, Scholes G, Loo JA, Milne J, Tegen SB, Kulp DT, Laskin J. Confronting Racism in Chemistry Journals. Mol Pharm. 2020 Jul 06;17(7):2229-2231. doi: 10.1021/acs.molpharmaceut.0c00638. Epub 2020 Jun 19. PMID: 32559104.
Copy Download .nbib Format: NLM
Republished: Severe hypothermia, bradycardia and cardiac arrest in association with risperidone.

Drug and therapeutics bulletin

Sharma N, Bhat S, Ravi D, Ochieng P.
PMID: 33093075
Drug Ther Bull. 2021 Jan;59(1):13-15. doi: 10.1136/dtb.2020.234999rep. Epub 2020 Oct 22.

No abstract available.

Cite
Sharma N, Bhat S, Ravi D, et al. Republished: Severe hypothermia, bradycardia and cardiac arrest in association with risperidone. Drug Ther Bull. 2020;59(1):13-15doi: 10.1136/dtb.2020.234999rep.
Sharma, N., Bhat, S., Ravi, D., & Ochieng, P. (2021). Republished: Severe hypothermia, bradycardia and cardiac arrest in association with risperidone. Drug and therapeutics bulletin, 59(1), 13-15. https://doi.org/10.1136/dtb.2020.234999rep
Sharma, Nishant, et al. "Republished: Severe hypothermia, bradycardia and cardiac arrest in association with risperidone." Drug and therapeutics bulletin vol. 59,1 (2021): 13-15. doi: https://doi.org/10.1136/dtb.2020.234999rep
Sharma N, Bhat S, Ravi D, Ochieng P. Republished: Severe hypothermia, bradycardia and cardiac arrest in association with risperidone. Drug Ther Bull. 2021 Jan;59(1):13-15. doi: 10.1136/dtb.2020.234999rep. Epub 2020 Oct 22. PMID: 33093075.
Copy Download .nbib Format: NLM
Showing 145 to 156 of 165 entries